Esprit Pharma, Inc.

16 articles about Esprit Pharma, Inc.

• Allergan Inc. (Jobs) Announces Agreement to Acquire Esprit Pharma, Inc. for $370 Million

  9/19/2007

• Indevus Pharmaceuticals, Inc. Announces Receipt of $49.9 Million Milestone Payment from Esprit Pharma, Inc.

  8/13/2007

• Esprit Pharma, Inc. Secures Marketing Rights to SANCTURA(R) XR Creating a New Benchmark for Tolerability in the Treatment of Overactive Bladder

  8/13/2007

• Esprit Pharma, Inc. Elects Robert E. Baldini to Its Board of Directors

  5/3/2007

• Depomed, Inc. Receives $10 Million License Fee From Esprit Pharma, Inc. And Withdraws Arbitration Proceeding

  12/22/2006

• Indevus Pharmaceuticals, Inc. Announces Receipt Of $10 Million Milestone Payment From Esprit Pharma, Inc.

  10/18/2006

• Esprit Pharma, Inc. Successfully Completes Series B Financing, Raising In Excess Of $90M

  8/2/2006

• Depomed, Inc. Takes Action To Support Momentum In ProQuin(R) XR Sales; Company Amends Marketing Agreement With Esprit Pharma, Inc.

  7/24/2006

• Depomed, Inc. Provides Update On Esprit Pharma, Inc. Agreement

  7/24/2006

• Esprit Pharma, Inc. Acquires Exclusive North American Rights To A Novel Treatment For Hypoactive Sexual Desire Disorder In Women From Novavax, Inc.

  5/19/2006

• Esprit Pharma, Inc. Appoints Vice President Of Trade

  5/11/2006

• Depomed, Inc. And Esprit Pharma, Inc. Announce Availability Of ProQuin(R)XR 3-Tablet Blister Packs

  4/26/2006

• Esprit Pharma, Inc. Secures $50 Million Credit Facility, Further Positioning Itself To Build Upon Current Growth Momentum

  3/29/2006

• Esprit Pharma, Inc. Expands Relationship With Esprit Pharma, Inc.

  2/15/2006

• Esprit Pharma, Inc. Acquires Exclusive North American Rights To ESTRASORB(R) Topical Emulsion

  10/19/2005

• The Day In Review: Biotech Climbs Modestly

  7/11/2005